Related Experiment Video
Updated: Jun 22, 2025
RNAi Trigger Delivery into Anopheles gambiae Pupae
Published on: March 8, 2016
Exploring Genetic Silencing: RNAi and CRISPR-Cas Potential against Drug Resistance in Malaria
Carlos Gaona-Lopez1, Gildardo Rivera1
1Laboratorio de Biotecnologia Farmaceutica, Centro de Biotecnologia Genomica, Instituto Politecnico Nacional, Reynosa, 88710, Mexico.
Abstract:
Malaria has been one of the most lethal infectious diseases throughout history, claiming a high number of human lives. The genomic plasticity of Plasmodium falciparum, the causative agent of the most severe and deadly form of malaria, gives the parasite a constant resistance to drugs developed for its control. Despite efforts to control and even eradicate the disease, these have largely been unsuccessful due to the parasite's continuous adaptations. This study aims to examine the key genes involved in parasite resistance and propose a shift in the combat strategy. Gene silencing techniques offer promise in combating malaria, yet further research is needed to harness their potential for disease control fully. Although there is still a long way to go for the implementation of gene silencing-based therapeutic strategies, this review addresses examples of the use of such techniques in various human diseases and how they could be extrapolated for malaria treatment.
Insights
Malaria remains a deadly disease due to Plasmodium falciparum's drug resistance. Gene silencing offers a novel strategy to combat malaria, though further research is needed for its application.
Area of Science:
- Infectious Diseases
- Genetics
- Parasitology
Background:
- Malaria is a historically lethal infectious disease with high mortality rates.
- Plasmodium falciparum, the deadliest malaria parasite, exhibits genomic plasticity leading to drug resistance.
- Current control efforts are hampered by the parasite's continuous adaptation.
Purpose of the Study:
- To investigate genes crucial for Plasmodium falciparum resistance.
- To propose a new strategy for malaria control.
- To explore the potential of gene silencing for malaria treatment.
Main Methods:
- Review of existing literature on malaria parasite resistance mechanisms.
- Analysis of gene silencing techniques in other human diseases.
- Extrapolation of gene silencing strategies for malaria control.
Main Results:
- Identification of key genes contributing to parasite resistance.
- Demonstration of gene silencing efficacy in other diseases.
- Potential for gene silencing as a novel therapeutic approach.
Conclusions:
- Gene silencing presents a promising avenue for malaria control.
- Further research is essential to fully realize gene silencing's therapeutic potential.
- Adapting gene silencing techniques could revolutionize malaria treatment strategies.
Related Concept Videos
02:15Experimental RNAi
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:59CRISPR
01:22MicroRNAs